Medicare Cuts Cost of 10 Common Drugs Covered by Part D

被引：0
|
作者：
Anderer, Samantha
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2024年 / 332卷 / 14期
关键词：
D O I：
10.1001/jama.2024.18192
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Cost Sharing for Preferred Branded Drugs in Medicare Part D
    Trish, Erin
    Blaylock, Barbara
    Van Nuys, Karen
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025, 333 (13): : 1170 - 1172
  • [2] Medicare Part D spending for the 10 costliest oral anticancer drugs
    McBride, Kaitlyn
    Snyder, Sophie
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)
  • [3] Identifying widely covered drugs and drug coverage variation among Medicare Part D formularies
    Tseng, Chien-Wen
    Mangione, Carol M.
    Brook, Robert H.
    Keeler, Emmett
    Dudley, R. Adams
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (23): : 2596 - 2602
  • [4] The Effects of Medicare Part D on Health Outcomes of Newly Covered Medicare Beneficiaries
    Diebold, Jeffrey
    JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES, 2018, 73 (05): : 890 - 900
  • [5] Coverage for High-Cost Specialty Drugs for Rheumatoid Arthritis in Medicare Part D
    Yazdany, Jinoos
    Dudley, R. Adams
    Chen, Randi
    Lin, Grace A.
    Tseng, Chien-Wen
    ARTHRITIS & RHEUMATOLOGY, 2015, 67 (06) : 1474 - 1480
  • [6] Availability of Cost-effectiveness Studies for Drugs With High Medicare Part D Expenditures
    Tisdale, Rebecca L.
    Ma, Iris
    Vail, Daniel
    Bhattacharya, Jay
    Goldhaber-Fiebert, Jeremy D.
    Heidenreich, Paul A.
    Sandhu, Alexander T.
    JAMA NETWORK OPEN, 2021, 4 (06)
  • [7] Coverage of New Drugs in Medicare Part D
    Naci, Huseyin
    Kyriopoulos, Ilias
    Feldman, William B.
    Hwang, Thomas J.
    Kesselheim, Aaron S.
    Chandra, Amitabh
    MILBANK QUARTERLY, 2022, 100 (02): : 562 - 588
  • [8] Your Money or Your Life - The High Cost of Cancer Drugs under Medicare Part D
    Dusetzina, Stacie B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (23): : 2164 - 2167
  • [9] Medicare Part D: Patients Bear The Cost Of 'Me Too' Brand-Name Drugs
    Gastala, Nicole M.
    Wingrove, Peter
    Gaglioti, Anne
    Petterson, Stephen
    Bazemore, Andrew
    HEALTH AFFAIRS, 2016, 35 (07) : 1237 - 1240
  • [10] Access to cancer drugs in Medicare Part D: Formulary placement and beneficiary cost sharing in 2006
    Bowman, Jennifer
    Rousseau, Amy
    Silk, David
    Harrison, Catherine
    HEALTH AFFAIRS, 2006, 25 (05) : 1240 - 1248
12345